PURPOSE: Sentinel lymph node biopsy (SLNB) is standard of care in early-stage breast cancer. Freehand SPECT (FhSPECT) is a system generating 3-D images for intraoperative visual detection of radioactivity in the body. The aim of our study was to evaluate the sensitivity of this technology for sentinel lymph node (SLN) detection and SLNB guidance. METHODS: In 40 patients, FhSPECT was additionally used after planar imaging and probe localization for SLNB. The number of SLNs detected was compared with the number detected by planar scintigraphy (reference method) and the conventional acoustic gamma probe (standard alternative). The sensitivity of FhSPECT was compared with that of the conventional gamma probe (McNemar's test). RESULTS: FhSPECT mapped the SLNs in 92.3 % of the basins (36/39) intraoperatively in identical positions to those seen on planar scintigrams. The conventional gamma probe correctly detected the SLNs in 35 of 39 basins (89.7 %). After SLNB, remaining radioactivity was detected by FhSPECT in nine patients, resulting in additional resection of SLNs in four patients. CONCLUSION: FhSPECT is a highly sensitive modality for intraoperative detection of SLNs, resulting in the identification of a higher number of SLNs than conventional gamma probe detection.
PURPOSE: Sentinel lymph node biopsy (SLNB) is standard of care in early-stage breast cancer. Freehand SPECT (FhSPECT) is a system generating 3-D images for intraoperative visual detection of radioactivity in the body. The aim of our study was to evaluate the sensitivity of this technology for sentinel lymph node (SLN) detection and SLNB guidance. METHODS: In 40 patients, FhSPECT was additionally used after planar imaging and probe localization for SLNB. The number of SLNs detected was compared with the number detected by planar scintigraphy (reference method) and the conventional acoustic gamma probe (standard alternative). The sensitivity of FhSPECT was compared with that of the conventional gamma probe (McNemar's test). RESULTS: FhSPECT mapped the SLNs in 92.3 % of the basins (36/39) intraoperatively in identical positions to those seen on planar scintigrams. The conventional gamma probe correctly detected the SLNs in 35 of 39 basins (89.7 %). After SLNB, remaining radioactivity was detected by FhSPECT in nine patients, resulting in additional resection of SLNs in four patients. CONCLUSION: FhSPECT is a highly sensitive modality for intraoperative detection of SLNs, resulting in the identification of a higher number of SLNs than conventional gamma probe detection.
Authors: H Vogt; M Schmidt; R Bares; W Brenner; F Grünwald; J Kopp; C Reiners; O Schober; C Schümichen; H Schicha; J Sciuk; F Sudbrock; H Wengenmair Journal: Nuklearmedizin Date: 2010-05-19 Impact factor: 1.379
Authors: Thorsten Kuehn; Andreas Bembenek; Thomas Decker; Dieter Ludwig Munz; Marie-Luise Sautter-Bihl; Michael Untch; Diethelm Wallwiener Journal: Cancer Date: 2005-02-01 Impact factor: 6.860
Authors: John Buscombe; Giovanni Paganelli; Zeynep E Burak; Wendy Waddington; Jean Maublant; Enrique Prats; Holger Palmedo; Orazio Schillaci; Lorenzo Maffioli; M Lassmann; Carlo Chiesa; Emilio Bombardieri; Arturo Chiti Journal: Eur J Nucl Med Mol Imaging Date: 2007-12 Impact factor: 9.236
Authors: Thomas Wendler; Ken Herrmann; Andreas Schnelzer; Tobias Lasser; Joerg Traub; Olivier Kutter; Alexandra Ehlerding; Klemens Scheidhauer; Tibor Schuster; Marion Kiechle; Markus Schwaiger; Nassir Navab; Sibylle I Ziegler; Andreas K Buck Journal: Eur J Nucl Med Mol Imaging Date: 2010-03-31 Impact factor: 9.236
Authors: Susan L Troyan; Vida Kianzad; Summer L Gibbs-Strauss; Sylvain Gioux; Aya Matsui; Rafiou Oketokoun; Long Ngo; Ali Khamene; Fred Azar; John V Frangioni Journal: Ann Surg Oncol Date: 2009-07-07 Impact factor: 5.344
Authors: Christina Bluemel; Andreas Cramer; Christoph Grossmann; Georg W Kajdi; Uwe Malzahn; Nora Lamp; Heinz-Jakob Langen; Jan Schmid; Andreas K Buck; Hanns-Jörg Grimminger; Ken Herrmann Journal: Eur J Nucl Med Mol Imaging Date: 2015-07-09 Impact factor: 9.236
Authors: Christina Bluemel; Domenico Rubello; Patrick M Colletti; Remco de Bree; Ken Herrmann Journal: Eur J Nucl Med Mol Imaging Date: 2015-04-28 Impact factor: 9.236
Authors: Thijs Engelen; Beatrice Mf Winkel; Daphne Dd Rietbergen; Gijs H KleinJan; Sergi Vidal-Sicart; Renato A Valdés Olmos; Nynke S van den Berg; Fijs Wb van Leeuwen Journal: Am J Nucl Med Mol Imaging Date: 2015-02-15
Authors: Christina Bluemel; Ken Herrmann; Alexander Kübler; Andreas K Buck; Eva Geissinger; Vanessa Wild; Stefan Hartmann; Constantin Lapa; Christian Linz; Urs Müller-Richter Journal: Eur J Nucl Med Mol Imaging Date: 2014-07-31 Impact factor: 9.236
Authors: Matthias N van Oosterom; Hervé Simon; Laurent Mengus; Mick M Welling; Henk G van der Poel; Nynke S van den Berg; Fijs Wb van Leeuwen Journal: Am J Nucl Med Mol Imaging Date: 2016-01-28
Authors: Christina Bluemel; Gonca Safak; Andreas Cramer; Achim Wöckel; Anja Gesierich; Elena Hartmann; Jan-Stefan Schmid; Franz Kaiser; Andreas K Buck; Ken Herrmann Journal: Eur J Nucl Med Mol Imaging Date: 2016-06-17 Impact factor: 9.236
Authors: Tuula Peñate Medina; Jan Philip Kolb; Gereon Hüttmann; Robert Huber; Oula Peñate Medina; Linh Ha; Patricia Ulloa; Naomi Larsen; Arianna Ferrari; Magdalena Rafecas; Mark Ellrichmann; Mariya S Pravdivtseva; Mariia Anikeeva; Jana Humbert; Marcus Both; Jennifer E Hundt; Jan-Bernd Hövener Journal: Front Immunol Date: 2021-06-24 Impact factor: 7.561
Authors: Michał Nieciecki; Katarzyna Dobruch-Sobczak; Paweł Wareluk; Anna Gumińska; Ewa Białek; Marek Cacko; Leszek Królicki Journal: J Ultrason Date: 2016-03-29